Perspectives for novel mixed diruthenium-organic drugs as metallopharmaceuticals in cancer therapy (2010)
- Autor:
- Autor USP: SILVA, DENISE DE OLIVEIRA - IQ
- Unidade: IQ
- Subjects: ANTI-INFLAMATÓRIOS NÃO ESTEROIDES; COMPOSTOS DE COORDENAÇÃO; ANTINEOPLÁSICOS (ATIVIDADE)
- Language: Inglês
- Imprenta:
- Source:
- Título: Anti-Cancer Agents in Medicinal Chemistry
- ISSN: 1871-5206
- Volume/Número/Paginação/Ano: v. 10, n. 4, p. 312-323, 2010
-
ABNT
SILVA, Denise de Oliveira. Perspectives for novel mixed diruthenium-organic drugs as metallopharmaceuticals in cancer therapy. Anti-Cancer Agents in Medicinal Chemistry, v. 10, n. 4, p. 312-323, 2010Tradução . . Disponível em: http://docstore.ingenta.com/cgi-bin/ds_deliver/1/u/d/ISIS/58312628.1/ben/acamc/2010/00000010/00000004/art00006/F0AEB97433A916471282681475F9886F0D732F7F53.pdf?link=http://www.ingentaconnect.com/error/delivery&format=pdf. Acesso em: 15 abr. 2026. -
APA
Silva, D. de O. (2010). Perspectives for novel mixed diruthenium-organic drugs as metallopharmaceuticals in cancer therapy. Anti-Cancer Agents in Medicinal Chemistry, 10( 4), 312-323. Recuperado de http://docstore.ingenta.com/cgi-bin/ds_deliver/1/u/d/ISIS/58312628.1/ben/acamc/2010/00000010/00000004/art00006/F0AEB97433A916471282681475F9886F0D732F7F53.pdf?link=http://www.ingentaconnect.com/error/delivery&format=pdf -
NLM
Silva D de O. Perspectives for novel mixed diruthenium-organic drugs as metallopharmaceuticals in cancer therapy [Internet]. Anti-Cancer Agents in Medicinal Chemistry. 2010 ; 10( 4): 312-323.[citado 2026 abr. 15 ] Available from: http://docstore.ingenta.com/cgi-bin/ds_deliver/1/u/d/ISIS/58312628.1/ben/acamc/2010/00000010/00000004/art00006/F0AEB97433A916471282681475F9886F0D732F7F53.pdf?link=http://www.ingentaconnect.com/error/delivery&format=pdf -
Vancouver
Silva D de O. Perspectives for novel mixed diruthenium-organic drugs as metallopharmaceuticals in cancer therapy [Internet]. Anti-Cancer Agents in Medicinal Chemistry. 2010 ; 10( 4): 312-323.[citado 2026 abr. 15 ] Available from: http://docstore.ingenta.com/cgi-bin/ds_deliver/1/u/d/ISIS/58312628.1/ben/acamc/2010/00000010/00000004/art00006/F0AEB97433A916471282681475F9886F0D732F7F53.pdf?link=http://www.ingentaconnect.com/error/delivery&format=pdf - Perspectives on combined metallodrugs of ruthenium/nonsteroidal anti-inflammatories for treatment of tumors
- Synthesis and characterization of ruthenium-phosphine derived complex containing the non-steroidal anti-inflammatory naproxen drug
- Síntese de um complexo de rutênio-ibuprofeno empregando reator de microondas
- Investigação da interação entre cobre(II) e os fármacos antiinflamatórios não-esteróides: diclofenaco, tolmetin e naproxeno
- Diruthenium(II,III) metallodrugs of ibuprofen and naproxen encapsulated in intravenously injectable polymer-lipid nanoparticles exhibit enhanced activity against breast and prostate cancer cells
- Chemical behavior of chloridotetrakis(ibuprofeno)diruthenium(ll,lll) metallodrug in acidic solution
- Crystallographic disorder of the 'M IND.2' units in ' ['m ind.2' E 'cl ind.8'] POT.N-' ( m='MO', 'RE') compouds
- Thermodynamics of axial substitution and kinetics of reactions with amino acids for the paddlewheel complex tetrakis(acetato)chloridodiruthenium(II,III)
- A Ru(II)-p-cymene compound bearing naproxen-pyridineamide. Synthesis, spectroscopic studies, computational analysis and in vitro anticancer activity against lung cells compared to Ru(II)-p-cymene-naproxen and the corresponding drug ligands
- Preparação de microesferas de quitosana reticulada e adsorção de um metalofármaco de cobre-naproxeno
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
